home All News open_in_new Full Article

Patients struggle with lack of consistent coverage for popular weight

Supplies of high-demand obesity treatments are improving, but that doesn’t mean it’s easier to get them. Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t cover the drugs for obesity. Meanwhile, some big employers are adding coverage, but their commitment isn’t guaranteed. Treatment prices that […]


today 4 h. ago attach_file Science

attach_file Science
attach_file Economics
attach_file Science
attach_file Politics
attach_file Other
attach_file Science
attach_file Society
attach_file Events
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Economics
attach_file Events
attach_file Economics


ID: 1038163378
Add Watch Country

arrow_drop_down